Shares of Research Solutions Inc. (NASDAQ:RSSS – Get Free Report) have earned a consensus recommendation of “Hold” from the five brokerages that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $3.83.
Separately, Weiss Ratings cut Research Solutions from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, October 9th.
View Our Latest Stock Report on Research Solutions
Hedge Funds Weigh In On Research Solutions
Research Solutions Trading Down 0.3%
Shares of NASDAQ:RSSS opened at $1.96 on Thursday. Research Solutions has a 1-year low of $1.90 and a 1-year high of $3.54. The firm has a market capitalization of $66.17 million, a PE ratio of 21.78 and a beta of 0.77. The business’s 50 day moving average is $2.14 and its 200-day moving average is $2.26.
Research Solutions (NASDAQ:RSSS – Get Free Report) last released its quarterly earnings data on Wednesday, September 9th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02). The firm had revenue of $12.08 million for the quarter, compared to the consensus estimate of $11.95 million. Research Solutions had a net margin of 5.84% and a return on equity of 15.55%. On average, sell-side analysts predict that Research Solutions will post 0.10 EPS for the current year.
About Research Solutions
Research Solutions, Inc is a technology company that provides digital tools and marketplaces for the life sciences research industry. Its platforms are designed to help scientists discover, evaluate and procure research products, services and external laboratory capabilities.
The company’s offerings include Scientist.com, a research marketplace that connects pharmaceutical, biotechnology, academic and government organizations with suppliers and contract research providers. The platform supports the sourcing and management of outsourced research activities, including laboratory services, testing and other specialized scientific capabilities.
Research Solutions also operates Bioz, a search and discovery platform that helps researchers identify scientific products and assess their use in published research.
See Also
- Five stocks we like better than Research Solutions
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for Research Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
